LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · IEX Real-Time Price · USD
2.647
-0.113 (-4.09%)
At close: May 17, 2024, 3:59 PM
2.740
+0.093 (3.51%)
After-hours: May 17, 2024, 5:17 PM EDT
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $70.45 million as of May 17, 2024. Its market cap has increased by 41.19% in one year.
Market Cap
70.45M
Enterprise Value
-26.65M
1-Year Change
41.19%
Ranking
Category
Stock Price
$2.65
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $70.45M, a decrease of -81.47%. That is a compound annual growth rate of -41.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 69.40M | -4.41% |
| May 16, 2024 | 72.60M | -2.42% |
| May 15, 2024 | 74.40M | -2.11% |
| May 14, 2024 | 76.00M | -5.47% |
| May 13, 2024 | 80.40M | -0.99% |
| May 10, 2024 | 81.20M | -0.73% |
| May 9, 2024 | 81.80M | 0.99% |
| May 8, 2024 | 81.00M | 2.66% |
| May 7, 2024 | 78.90M | 5.62% |
| May 6, 2024 | 74.70M | -6.27% |
| May 3, 2024 | 79.70M | -2.21% |
| May 2, 2024 | 81.50M | 4.35% |
| May 1, 2024 | 78.10M | 2.76% |
| Apr 30, 2024 | 76.00M | -0.26% |
| Apr 29, 2024 | 76.20M | 6.13% |
| Apr 26, 2024 | 71.80M | 3.46% |
| Apr 25, 2024 | 69.40M | -3.61% |
| Apr 24, 2024 | 72.00M | -8.05% |
| Apr 23, 2024 | 78.30M | 4.54% |
| Apr 22, 2024 | 74.90M | 5.20% |
| Apr 19, 2024 | 71.20M | -4.30% |
| Apr 18, 2024 | 74.40M | -3.75% |
| Apr 17, 2024 | 77.30M | 1.71% |
| Apr 16, 2024 | 76.00M | -1.30% |
| Apr 15, 2024 | 77.00M | -6.44% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 72.16M |
| MAIA Biotechnology | 72.06M |
| Asensus Surgical | 70.81M |
| Silver Spike Investment | 70.63M |
| Tempest Therapeutics | 70.54M |
| MediciNova | 70.39M |
| Journey Medical | 70.25M |
| Landos Biopharma | 70.24M |